Wedbush Maintains Neutral on Ultragenyx Pharmaceutical, Raises Price Target to $48

benzinga_article
2024.02.16 13:58

Wedbush 分析師 Laura Chico 維持 Ultragenyx Pharmaceutical（NASDAQ:RARE）的中性評級，並將目標股價從 47 美元上調至 48 美元。

Wedbush 分析師 Laura Chico 維持對 Ultragenyx Pharmaceutical（NASDAQ:RARE）的中性評級，並將目標股價從 47 美元上調至 48 美元。

Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.